home / stock / crmd / crmd news

CRMD News and Press, CorMedix Inc. From 09/08/23

Stock Information
Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com
Menu
CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...
CRMD - SAGE, XERS and LOVE are among after hour movers

2023-09-08 17:10:24 ET Gainers: Vigil Neuroscience ( NASDAQ: VIGL ) +7% . Tenaya Therapeutics ( TNYA ) +4% . CorMedix ( CRMD ) +4% . Xeris Biopharma  ( XERS ) +3% . Avidity Biosciences ( RNA ) +3% . Losers: The L...
CRMD - CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the publication of its ...

CRMD - OCUL, CBAY and CRMD are among after hour movers

2023-09-07 17:10:58 ET Gainers: Smith & Wesson Brands  ( SWBI ) +11% . CymaBay Therapeutics ( CBAY ) +5% . DocuSign ( DOCU ) +5% . Ocular Therapeutix ( OCUL ) +4% . CorMedix  ( CRMD ) +4% . Losers: Altisourc...

CRMD - CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath

BERKELEY HEIGHTS, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that the United States P...
CRMD - CorMedix (CRMD) Q2 2023 Earnings Call Transcript

2023-08-08 17:00:24 ET Image source: The Motley Fool. CorMedix (NASDAQ: CRMD) Q2 2023 Earnings Call Aug 08, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: CorMedix (CRMD) Q2 2023 Earnings Call Transcript

CRMD - CorMedix Inc. (CRMD) Q2 2023 Earnings Call Transcript

2023-08-08 12:57:10 ET CorMedix Inc. (CRMD) Q2 2023 Earnings Conference Call August 08, 2023, 08:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors Joseph Todisco - Chief Executive Officer Matt David - Executive Vice President and Chief Financial Offic...

CRMD - CorMedix GAAP EPS of -$0.25 misses by $0.01

2023-08-08 07:33:48 ET CorMedix press release ( NASDAQ: CRMD ): Q2 GAAP EPS of -$0.25 misses by $0.01 . Joe Todisco, CorMedix CEO, commented, “we are pleased with the progress that we have made toward our goal of achieving a potential FDA approval of DefenCath l...
CRMD - CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced financial results for th...

CRMD - Notable earnings before Tuesday's open

2023-08-07 11:20:35 ET Major earnings expected before the bell on Tuesday include: Duke Energy ( DUK ) Barrick Gold ( GOLD ) Medical Properties Trust ( MPW ) Organon ( OGN ) United Parcel Service ( UPS ) For further details see: Notable ea...

CRMD - CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023

BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will report ...
Previous 10 Next 10